All Stories

  1. Dientamoeba fragilis, the Neglected Trichomonad of the Human Bowel
  2. Epidemiology and geographical distribution of enteric protozoan infections in Sydney, Australia
  3. Description of Dientamoeba fragilis Cyst and Precystic Forms from Human Samples
  4. Anncaliia algerae Microsporidial Myositis
  5. Evaluation of the EasyScreen™ Enteric Parasite Detection Kit for the detection of Blastocystis spp., Cryptosporidium spp., Dientamoeba fragilis, Entamoeba complex, and Giardia intestinalis from clinical stool samples
  6. Update on the pathogenic potential and treatment options for Blastocystis sp
  7. Improved detection of gastrointestinal pathogens using generalised sample processing and amplification panels
  8. Activity of benzimidazoles againstDientamoeba fragilis(Trichomonadida, Monocercomonadidae)in vitroand correlation of beta-tubulin sequences as an indicator of resistance
  9. Treatment failure in patients with chronic Blastocystis infection
  10. Cyst formation and faecal–oral transmission of Dientamoeba fragilis – the missing link in the life cycle of an emerging pathogen
  11. Subtype distribution of Blastocystis isolates from a variety of animals from New South Wales, Australia
  12. Optimization of microbial screening for cord blood
  13. Effects of cryopreservation on microbial‐contaminated cord blood
  14. Gastrointestinal pathogen distribution in symptomatic children in Sydney, Australia
  15. Current treatment options for Dientamoeba fragilis infections
  16. Subtype distribution of Blastocystis isolates identified in a Sydney population and pathogenic potential of Blastocystis
  17. 134. Cytotoxic and Proteolytic Molecules of the Human Parasite Dientamoeba fragilis, Identified by RNA seq, Provide Support for its Pathogenic Capacity
  18. Enteric Protozoa in the Developed World: a Public Health Perspective
  19. Myositis due to the microsporidian Anncaliia (Brachiola) algerae in a lung transplant recipient
  20. New advances in thein-vitroculture ofDientamoeba fragilis
  21. A microscopic description and ultrastructural characterisation of Dientamoeba fragilis: An emerging cause of human enteric disease
  22. Detection and Transmission of Dientamoeba fragilis from Environmental and Household Samples
  23. Factors affecting microbial contamination rate of cord blood collected for transplantation
  24. In VitroSusceptibility Testing of Dientamoeba fragilis
  25. Prevalence of gastrointestinal pathogens in Sub-Saharan Africa: systematic review and meta-analysis
  26. Blastocystis infection is associated with irritable bowel syndrome in a Mexican patient population
  27. A case-controlled study of Dientamoeba fragilis infections in children
  28. The ambiguous life ofDientamoeba fragilis: the need to investigate current hypotheses on transmission
  29. Comparison of Microscopy, Culture, and Conventional Polymerase Chain Reaction for Detection of Blastocystis sp. in Clinical Stool Samples
  30. A review ofDientamoeba fragiliscarriage in humans: Several reasons why this organism should be considered in the diagnosis of gastrointestinal illness
  31. Evaluation of Multiplex Tandem Real-Time PCR for Detection of Cryptosporidium spp., Dientamoeba fragilis, Entamoeba histolytica, and Giardia intestinalis in Clinical Stool Samples
  32. Importance of Nonenteric Protozoan Infections in Immunocompromised People
  33. Seroprevalence of Entamoeba histolytica Infection among Men Who Have Sex with Men in Sydney, Australia
  34. Newly defined conditions for thein vitrocultivation and cryopreservation ofDientamoeba fragilis: new techniques set to fast track molecular studies on this organism
  35. A Review of the Clinical Presentation of Dientamoebiasis
  36. Comparison of microscopy, two xenic culture techniques, conventional and real-time PCR for the detection of Dientamoeba fragilis in clinical stool samples
  37. Clinical Significance of Enteric Protozoa in the Immunosuppressed Human Population
  38. Repeated Dientamoeba fragilis infections: a case report of two families from Sydney, Australia
  39. Clinical Significance and Phylogenetic Relationship of Novel Australian Pneumocystis jirovecii Genotypes
  40. Limited genetic diversity among genotypes of Enterocytozoon bieneusi strains isolated from HIV-infected patients from Sydney, Australia
  41. Absence of human Bocavirus in bronchoalveolar lavage fluid of lung transplant patients
  42. Leishmaniasis, an Emerging Imported Infection: Report of 20 Cases From Australia: Table 1
  43. MRSA detection: comparison of two molecular methods (BD GeneOhm® PCR assay and Easy-Plex) with two selective MRSA agars (MRSA-ID and Oxoid MRSA) for nasal swabs
  44. Invasive Amebiasis in Men Who Have Sex with Men, Australia
  45. Achromobacter xylosoxidans subsp. xylosoxidans prosthetic aortic valve infective endocarditis and aortic root abscesses
  46. Comparison of Stool Antigen Detection Kits to PCR for Diagnosis of Amebiasis
  47. Candida dubliniensis Meningitis as Delayed Sequela of Treated C. dubliniensis Fungemia
  48. Gorillas are a host for Dientamoeba fragilis: An update on the life cycle and host distribution
  49. Declining incidence of intestinal microsporidiosis and reduction in AIDS-related mortality following introduction of HAART in Sydney, Australia
  50. Entamoeba moshkovskii infections in Sydney, Australia
  51. Laboratory Diagnostic Techniques for Entamoeba Species
  52. Methicillin-Resistant Staphylococcus aureus (MRSA) Detection: Comparison of Two Molecular Methods (IDI-MRSA PCR Assay and GenoType MRSA Direct PCR Assay) with Three Selective MRSA Agars (MRSA ID, MRSASelect, and CHROMagar MRSA) for Use with Infection-C...
  53. Rhizopus microsporus var. rhizopodiformis sinus-orbital zygomycosis in an immunosuppressed patient: successful treatment with posaconazole after a complicated clinical course
  54. Lymphogranuloma Venereum in Australia: Anorectal Chlamydia trachomatis Serovar L2b in Men Who Have Sex with Men
  55. PCR Detection of Entamoeba histolytica, Entamoeba dispar, and Entamoeba moshkovskii in Stool Samples from Sydney, Australia
  56. Dientamoeba fragilis as a Cause of Travelers’ Diarrhea: Report of Seven Cases: Table 1
  57. Irritable bowel syndrome: A review on the role of intestinal protozoa and the importance of their detection and diagnosis
  58. Post-Kala-Azar Dermal Leishmaniasis Due to Leishmania infantum in a Human Immunodeficiency Virus Type 1-Infected Patient
  59. Dientamoebiasis: clinical importance and recent advances
  60. Evaluation of Three Diagnostic Methods, Including Real-Time PCR, for Detection of Dientamoeba fragilis in Stool Specimens
  61. Prospective Study of the Prevalence, Genotyping, and Clinical Relevance of Dientamoeba fragilis Infections in an Australian Population
  62. Detection of Dientamoeba fragilis in fresh stool specimens using PCR